http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201600290-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-787 |
| filingDate | 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201600290-A1 |
| titleOfInvention | VACCINE AGAINST THE HOSE OF HORSES "AKNTAI" |
| abstract | The invention relates to the field of veterinary medicine, in particular, to the prevention and treatment of myta horses. The technical result provided by the invention, is expressed in obtaining a stable, harmless and highly effective vaccine against the specified infection. Vaccine against horse myta, including mytny antigen, which additionally contains broad-spectrum antibiotics bicillin-5, sulfadimezin, trimethoprim, and polyoxidonium as an adjuvant and immunomodulating agent, in the following ratio of components, in 1 l: antigen from Streptococcus equi BNK 1,8 -2.0 × 10KOE; bitsillin-5 30-40 million units; sulfadimezin 1800-2000 mg; Trimethoprim 300-400 mg; polyoxidonium 80-120 mg; distilled water to 1 l. |
| priorityDate | 2015-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.